本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Royalty Pharma plc

46.21
+0.85001.87%
盤後46.210.00000.00%19:01 EST
成交量:417.69萬
成交額:1.93億
市值:269.48億
市盈率:25.94
高:46.37
開:45.44
低:45.26
收:45.36
52周最高:46.37
52周最低:29.66
股本:5.83億
流通股本:3.80億
量比:1.34
換手率:1.10%
股息:0.88
股息率:1.90%
每股收益(TTM):1.78
每股收益(LYR):1.78
淨資產收益率:13.20%
總資產收益率:5.15%
市淨率:4.16
市盈率(LYR):25.94

資料載入中...

2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report